InVivo Therapeutics Holdings Profit Margin 2006-2019 | NVIV

Current and historical gross margin, operating margin and net profit margin for InVivo Therapeutics Holdings (NVIV) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. InVivo Therapeutics Holdings net profit margin as of June 30, 2019 is 0%.
InVivo Therapeutics Holdings Annual Profit Margins
InVivo Therapeutics Holdings Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.006B $0.000B
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $151.219B 28.42
Medtronic (MDT) Ireland $139.722B 19.96
Stryker (SYK) United States $81.794B 28.28
Boston Scientific (BSX) United States $59.536B 28.88
Baxter (BAX) United States $44.863B 27.20
EssilorLuxottica Societe Anonyme (ESLOY) France $31.074B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.448B 18.21
Coloplast (CLPBY) Denmark $26.704B 42.63
Lonza Group Ag (LZAGY) Switzerland $26.310B 0.00
Terumo (TRUMY) Japan $23.667B 27.21
Smith & Nephew SNATS (SNN) United Kingdom $20.451B 0.00
ResMed (RMD) United States $19.539B 37.26
Sunny Optical Technology (SNPTF) China $14.084B 0.00
Bio-Rad Laboratories (BIO) United States $9.862B 52.87
Canopy Growth (CGC) Canada $9.263B 0.00
Insulet (PODD) United States $9.194B 544.79
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $7.053B 21.03
Haemonetics (HAE) United States $6.935B 52.33
Perrigo (PRGO) Ireland $6.404B 11.80
Aurora Cannabis (ACB) Canada $5.942B 58.40
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
GW Pharmaceuticals (GWPH) United Kingdom $4.650B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.753B 62.43
ICU Medical (ICUI) United States $3.439B 22.31
NuVasive (NUVA) United States $3.331B 26.56
Hutchison China MediTech (HCM) China $2.666B 0.00
Agios Pharmaceuticals (AGIO) United States $2.562B 0.00
Quidel (QDEL) United States $2.554B 25.36
National Vision Holdings (EYE) United States $2.159B 46.61
Cardiovascular Systems (CSII) United States $1.736B 0.00
Aphria (APHA) $1.566B 0.00
Phibro Animal Health (PAHC) United States $1.291B 19.34
AtriCure (ATRC) United States $1.066B 0.00
VAREX IMAGING (VREX) United States $1.036B 23.87
Omeros (OMER) United States $1.013B 0.00
NanoString Technologies (NSTG) United States $1.001B 0.00
PetIQ (PETQ) United States $0.921B 21.75
Lantheus Holdings (LNTH) United States $0.917B 24.09
Eagle Pharmaceuticals (EGRX) United States $0.805B 20.53
Cerus (CERS) United States $0.782B 0.00
MacroGenics (MGNX) United States $0.742B 0.00
Quanterix (QTRX) United States $0.683B 0.00
TG Therapeutics (TGTX) United States $0.648B 0.00
LeMaitre Vascular (LMAT) United States $0.625B 37.06
Surmodics (SRDX) United States $0.619B 117.64
OraSure Technologies (OSUR) United States $0.449B 20.77
Meridian Bioscience (VIVO) United States $0.431B 13.44
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.403B 0.00
BioLife Solutions (BLFS) United States $0.384B 126.25
United Health Products (UEEC) United States $0.378B 0.00
Utah Medical Products (UTMD) United States $0.347B 25.43
Zynex (ZYXI) United States $0.334B 35.48
Owens & Minor (OMI) United States $0.312B 9.36
Bovie Medical (APYX) United States $0.261B 0.00
Vapotherm (VAPO) United States $0.245B 0.00
Rockwell Medical (RMTI) United States $0.161B 0.00
Cytosorbents (CTSO) United States $0.157B 0.00
Chimerix (CMRX) United States $0.155B 0.00
Fonar (FONR) United States $0.152B 7.97
Female Health (VERU) United States $0.126B 0.00
InfuSystems Holdings (INFU) United States $0.095B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
United-Guardian (UG) United States $0.088B 20.71
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Nephros (NEPH) United States $0.054B 0.00
MRI INTERVENTNS (MRIC) United States $0.046B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Trinity Biotech (TRIB) Ireland $0.041B 14.33
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Myomo (MYO) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
GUARDION HEALTH (GHSI) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00